Work

Lifetime costs and life-years gained associated with apixaban, dabigatran, rivaroxaban, and warfarin for stroke prevention in atrial fibrillation

Year: 2013

Type: article

Source: Value in Health

DOI: 10.1016/j.jval.2013.03.1483

Authors: A.R. Harrington, E.P. Armstrong, P. Nolan, D.C. Malone

Institution: University of Arizona

Language: English

Topic: Atrial Fibrillation Management and Outcomes

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2051545422

FWCI: 0.454

Cites:

Cited by: 2

Related to: 10